Hubei Jumpcan Pharmaceutical Co Ltd (600566) — Long-term Investment Intensity

Latest as of December 2019: 1.2%

Hubei Jumpcan Pharmaceutical Co Ltd (600566) has a Long-term Investment Intensity of 1.2% as of December 2019. Long-term investments of CN¥106.62 Million represent 1.2% of total assets of CN¥8.66 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 600566 financial resilience to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

1.2%
LT Investments / Total Assets

Long-term Investments

CN¥106.62 Million
CNY

Total Assets

CN¥8.66 Billion
CNY

Country

China
SHG

Hubei Jumpcan Pharmaceutical Co Ltd Long-term Investment Intensity (2015–2019)

This chart shows how Hubei Jumpcan Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2015 to 2019. As of December 2019, the intensity stands at 1.2%, reflecting long-term investments of CN¥106.62 Million against total assets of CN¥8.66 Billion CNY. For the complete balance sheet picture, see Hubei Jumpcan Pharmaceutical Co Ltd balance sheet assets.

Annual Long-term Investment Intensity for Hubei Jumpcan Pharmaceutical Co Ltd (2015–2019)

The table below presents the year-by-year Long-term Investment Intensity for Hubei Jumpcan Pharmaceutical Co Ltd from 2015 to 2019, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read total liabilities of Hubei Jumpcan Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (CNY) Total Assets Change (pp)
2019 1.2% CN¥106.62 Million CN¥8.66 Billion ▲ +0.4 pp
2018 0.8% CN¥62.24 Million CN¥7.80 Billion ▲ +0.1 pp
2017 0.6% CN¥43.26 Million CN¥6.66 Billion ▼ -0.2 pp
2016 0.9% CN¥43.57 Million CN¥4.99 Billion ▼ -0.2 pp
2015 1.0% CN¥37.50 Million CN¥3.59 Billion
pp = percentage points